Light Mode
$20.10 ↑ +0.31 (+1.57%) Trading Up from the previous close of $19.79, $0.87 below the day’s high of $20.97
-5.73 (-21.78%) / 6M
Momentum, market sentiment, and recent alerts
GLSI reads very good: price sits above one of the two key moving averages, the 12-month move is +153.1%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.